SSC Debate: Backers See Spin-Offs, Foes Cite Priorities

[Editor's note: The recent vote in the U.S. House of Representatives on whether to spend $110 million to start building the superconducting supercollider turned out to be a breeze for proponents of the Texas project (see story on page 2). But even with the outcome of the House vote known, the debate offers a fascinating look at the arguments both sides are expected to use throughout the coming decade as Congress wrestles with funding for the $6 billion accelerator. Supporters, in an effort to bl


Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Supporters, in an effort to blunt criticism that the project is merely an expensive toy for a handful of high-Energy physicists, make broad claims for its practical uses, particularly in medicine. They also argue that it is essential to the preservation of U.S. superiority in science. Opponents stress that the project is prone to mismanagement, that it would drain funds from other research fields, and that the government's limited resources would be better spent on small-science projects that are more likely to benefit society.

The question of foreign participation is a sticky one: Both sides would like to see other countries share in the huge cost of the project, but neither side wants the U.S. to sacrifice the technological spin-offs from the SSC.

Following are excerpts from the June 28 House debate on an amendment offered by Rep. Dennis Eckart (D-Ohio) to strip all construction funds from an appropriations bill ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide